白化病
医学
眼白化病
赫尔曼斯基-普德拉克综合征
切迪亚克-东综合征
病理
皮肤病科
免疫学
遗传学
生物
纤维化
肺纤维化
作者
Shaghayegh Tajik,Mohammad Reza Fazlollahi,Zahra Alizadeh,Mohsen Badalzadeh,Massoud Houshmand,Anahita Razaghian,Seiamak Bahram,Anne Molitor,Raphaël Carapito,Mansoureh Shariat,Amir Ali Hamidieh,Nasrin Behniafard,Babak Abdolkarimi,Tahereh Rostami,Mostafa Moin,Zahra Pourpak
摘要
Abstract Background Primary immunodeficiency diseases (inborn errors of immunity) with partial albinism are a group of autosomal recessive syndromes including Chediak Higashi Syndrome (CHS), Griscelli Syndrome type 2 (GS2), Hermansky‐Pudlak Syndromes type 2 and 10 (HPS2, HPS10), Vici syndrome and P14/LAMTOR2 deficiency. Methods Twenty‐five patients including 10 CHS, 10 GS2, and 5 HPS2 were evaluated in this study within the last 10 years. Five cases with oculocutaneous albinism (OCA) and 5 healthy subjects without albinism were used as two control groups. Genetic analyses were performed by whole exome or panel sequencing or targeted Sanger sequencing. Subsequently, leukocyte granules in peripheral blood smear and hair shaft were examined as screening tests. Results Giant granules were only presented in the leukocytes cytoplasm of 10/10 CHS patients. The uneven cluster of pigments and giant melanin granules in hair samples were observed in 10/10 GS2 and 10/10 CHS patients, respectively. In both 5/5 OCA and 5/5 HPS2 patients, there were regular pigments in the middle of hair shafts. Genetic analyses were performed for all patients, revealing 7 novel variants in LYST gene for CHS patients and 4 novel variants in AP3B1 for HPS2 patients. Conclusion Receiving hematopoietic stem cell transplantation (HSCT) in a timely manner is crucial in CHS and GS2 patients; therefore, screening tests may provide a vital clue for early diagnosis in these patients. However, the final confirmation of CHS, GS2, and HPS2 disorders is done by genetic assay.
科研通智能强力驱动
Strongly Powered by AbleSci AI